PGI3 COST-EFFECTIVENESS OF PEG-IFN ALPHA 2A OR 2B PLUS RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C IN MEXICO
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)75407-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)75407-3/fulltext
Title :
PGI3 COST-EFFECTIVENESS OF PEG-IFN ALPHA 2A OR 2B PLUS RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C IN MEXICO
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75407-3&doi=10.1016/S1098-3015(10)75407-3
First page :
Section Title :
Open access? :
No
Section Order :
1335